[go: up one dir, main page]

AU2003229429A1 - Polyepitopes and mini-genes for cancer treatment - Google Patents

Polyepitopes and mini-genes for cancer treatment

Info

Publication number
AU2003229429A1
AU2003229429A1 AU2003229429A AU2003229429A AU2003229429A1 AU 2003229429 A1 AU2003229429 A1 AU 2003229429A1 AU 2003229429 A AU2003229429 A AU 2003229429A AU 2003229429 A AU2003229429 A AU 2003229429A AU 2003229429 A1 AU2003229429 A1 AU 2003229429A1
Authority
AU
Australia
Prior art keywords
polyepitopes
mini
genes
cancer treatment
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003229429A
Inventor
Philippe Moingeon
James Tartaglia
John A. Tine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Aventis Pasteur Ltd
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur Ltd, Aventis Pasteur SA filed Critical Aventis Pasteur Ltd
Publication of AU2003229429A1 publication Critical patent/AU2003229429A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24041Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2003229429A 2002-05-07 2003-05-07 Polyepitopes and mini-genes for cancer treatment Abandoned AU2003229429A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37841602P 2002-05-07 2002-05-07
US60/378,416 2002-05-07
PCT/CA2003/000672 WO2003095642A2 (en) 2002-05-07 2003-05-07 Polyepitopes and mini-genes for cancer treatment

Publications (1)

Publication Number Publication Date
AU2003229429A1 true AU2003229429A1 (en) 2003-11-11

Family

ID=29420399

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003229429A Abandoned AU2003229429A1 (en) 2002-05-07 2003-05-07 Polyepitopes and mini-genes for cancer treatment

Country Status (2)

Country Link
AU (1) AU2003229429A1 (en)
WO (1) WO2003095642A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007503834A (en) * 2003-09-05 2007-03-01 サノフィ パストゥール リミテッド Multi-antigen vector for melanoma
EP3842065A1 (en) * 2019-12-23 2021-06-30 Transgene Process for designing a recombinant poxvirus for a therapeutic vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2100620A1 (en) * 1999-09-16 2009-09-16 Eisai Corporation of North America Nucleic acids encoding polyepitope polypeptides

Also Published As

Publication number Publication date
WO2003095642A3 (en) 2004-04-01
WO2003095642A2 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
AU2003280004A1 (en) Hair treatment method
AU2003230750A1 (en) Compositions and methods for treating cancer
EP2671581B8 (en) Compositions and methods for treating cancer
AU2003259249A1 (en) Pyridazinylpiperazine derivatives for treating pain
AU2003226301A1 (en) Method of treating cancer
AU2003256253A1 (en) Aerosol for medical treatment and methods
AU2003224654A1 (en) Photodynamic therapy for pre-melanomas
AU2003283257A1 (en) Scalp treatment
AU2003256847A1 (en) Method of treating cancer
AU2003225535A1 (en) Methods and compositions for treating cancer
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2003222449A1 (en) Medicine for treating cancer
AU2003232044A1 (en) Composition and method for dermatological treatment
AU2003217832A1 (en) Catheter for treating vulnerable plaque
AU2003219160A1 (en) Methods and compositions for the treatment of cancer
AU2003223538A1 (en) Methods for the treatment of cancer
AU2002303230A1 (en) Combined hydrotreating and process
AU2003280558A1 (en) Method for treatment of cancer
AU2003298708A1 (en) GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER
AU2003229429A1 (en) Polyepitopes and mini-genes for cancer treatment
AU2003231803A1 (en) Treatment of cancer with mefloquire
AU2003285079A1 (en) Neurostimulation therapy manipulation
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer
AU2003275433A1 (en) Compositions and methods for treating pain
AU2004281077A1 (en) Methods and agents for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 481 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME AVENTISPASTEUR, LTD. , APPLICATION NO. 2003229429, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003